Middle East & Africa Influenza Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Vaccine Type, Virus Type, Technology, Route of Administration, and Target Group

List of Tables

The Middle East & Africa influenza vaccines market is expected to grow from US$ 374.35 million in 2022 to US$ 533.85 million by 2028; it is estimated to grow at a CAGR of 6.1% from 2022 to 2028.

Increase in Government Support to Promote Influenza Vaccination to Bolster Middle East & Africa Influenza Vaccines Market During Forecast Period

Leading players in the influenza vaccines market have multiple projects on drug delivery and biological pipelines based on proprietary technology. The most advanced candidate population in drug delivery completed 2 Phase I studies. The pipeline also includes a large number of compounds that have completed preclinical evaluation. Pipeline candidates are focused on unlocking the science of the immune system, human genetics, and cutting-edge technologies to develop innovative vaccines. Companies are investing in scientific and technical excellence to develop and introduce new vaccines and specific drugs against infectious diseases, including influenza. Vaccines and viral therapeutic candidates in the pipeline are capable of rapidly and specifically responding to the most pressing health threats in the Middle East & Africa. Thus, strong pipeline candidates for influenza vaccines are the latest trend in the Middle East & Africa influenza vaccines market.

Market Overview

The Middle East & Africa influenza vaccines market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. In 2022, South Africa was the largest market for influenza vaccines in the region. The market for influenza vaccines in the Middle East & Africa is anticipated to grow at a CAGR of 6.1% during the forecast period. The influenza vaccines market is expected to grow due to the rising population base, increasing cases of influenza, growing research studies across the region, and increasing healthcare facilities.

Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Influenza Vaccines Market Segmentation

The Middle East & Africa influenza vaccines market is segmented on the basis of vaccine type, virus type, technology, route of administration, target group, and country.

Based on vaccine type, the Middle East & Africa influenza vaccines market is bifurcated into quadrivalent vaccines and trivalent vaccines. The quadrivalent vaccines segment registered a larger share of the market in 2022.

Based on virus type, the Middle East & Africa influenza vaccines market is bifurcated into influenza virus type A and influenza virus type B. The influenza virus type A segment held a larger share of the market in 2022.

Based on technology, the Middle East & Africa influenza vaccines market is divided into egg-based and cell-based. The egg-based segment held a larger share of the market in 2022.

Based on route of administration, the Middle East & Africa influenza vaccines market is divided into injection and nasal spray. The injection segment held a larger share of the market in 2022.

Based on target group, the Middle East & Africa influenza vaccines market is segmented into infants, children, adults, and elderly people. The infants segment held the largest share of the market in 2022.

Based on country, the Middle East & Africa influenza vaccines market is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. Saudi Arabia dominated the market in 2022.

AstraZeneca; GlaxoSmithKline plc.; Mitsubishi Chemical Group Corporation; MYLAN N.V.; Sanofi; SEQIRUS; and Serum Institute of India Pvt. Ltd are the leading companies operating in the Middle East & Africa influenza vaccines market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa influenza vaccines market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa influenza vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Product Code: BMIRE00026955

1. Introduction

1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Middle East & Africa Influenza Vaccines Market - By Vaccine Type
- 1.3.2 Middle East & Africa Influenza Vaccines Market - By Virus Type
- 1.3.3 Middle East & Africa Influenza Vaccines Market - By Technology
- 1.3.4 Middle East & Africa Influenza Vaccines Market - By Route of Administration
- 1.3.5 Middle East & Africa Influenza Vaccines Market - By Target Group
- 1.3.6 Middle East & Africa Influenza Vaccines Market - By Country

2. Middle East & Africa Influenza Vaccines Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Middle East & Africa Influenza Vaccines Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Middle East and Africa PEST Analysis
4.3 Experts Opinion

5. Middle East & Africa Influenza Vaccines Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increase in Government Support to Promote Influenza Vaccination
- 5.1.2 Increasing Investment by Top Market Players and Governments
5.2 Market Restraints
- 5.2.1 High Cost of Vaccine Development
5.3 Market Opportunities
- 5.3.1 Emerging Economies
5.4 Future Trends
- 5.4.1 Strong Pipeline Candidates for Influenza Vaccines
5.5 Impact Analysis

6. Influenza Vaccine Market - Middle East & Africa Analysis

6.1 Middle East & Africa Influenza Vaccines Market, By Country - Forecasts And Analysis
6.2 Middle East & Africa Influenza Vaccines Market Revenue Forecasts And Analysis
- 6.2.1 Middle East & Africa: Influenza Vaccines Market, 2019-2028 (US$ Million)

7. Middle East & Africa Influenza Vaccines Market Analysis and Forecasts To 2028 - By Vaccine Type

7.1 Overview
7.2 Middle East & Africa Influenza Vaccines Market, By Vaccine Type 2022 & 2028 (%)
- 7.2.1 Middle East & Africa: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
7.3 Quadrivalent Vaccines
- 7.3.1 Overview
- 7.3.2 Quadrivalent Vaccines : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Trivalent Vaccines
- 7.4.1 Overview
- 7.4.2 Trivalent Vaccines : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

8. Middle East & Africa Influenza Vaccines Market Analysis and Forecasts To 2028 - By Virus Type

8.1 Overview
8.2 Middle East & Africa Influenza Vaccines Market, By Virus Type 2022 & 2028 (%)
- 8.2.1 Middle East & Africa: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
8.3 Influenza Virus Type A
- 8.3.1 Overview
- 8.3.2 Influenza Virus Type A : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Influenza Virus Type B
- 8.4.1 Overview
- 8.4.2 Influenza Virus Type B : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

9. Middle East & Africa Influenza Vaccines Market Analysis and Forecasts To 2028 - By Technology

9.1 Overview
9.2 Middle East & Africa Influenza Vaccines Market, By Technology 2022 & 2028 (%)
- 9.2.1 Middle East & Africa Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
9.3 Egg-based
- 9.3.1 Overview
- 9.3.2 Egg-based : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Cell-based
- 9.4.1 Overview
- 9.4.2 Cell-Based : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

10. Middle East & Africa Influenza Vaccines Market Analysis and Forecasts To 2028 - By Route of Administration

10.1 Overview
10.2 Middle East & Africa Influenza Vaccines Market, By Route of Administration 2022 & 2028 (%)
- 10.2.1 Middle East & Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
10.3 Injection
- 10.3.1 Overview
- 10.3.2 Injection : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Nasal Spray
- 10.4.1 Overview
- 10.4.2 Nasal Spray: Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11. Middle East & Africa Influenza Vaccines Market Analysis and Forecasts To 2028 - By Target Group

11.1 Overview
11.2 Middle East & Africa Influenza Vaccines Market, By Target Group 2022 & 2028 (%)
- 11.2.1 Middle East & Africa: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
11.3 Infants
- 11.3.1 Overview
- 11.3.2 Infants : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.4 Children
- 11.4.1 Overview
- 11.4.2 Children: Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.5 Adults
- 11.5.1 Overview
- 11.5.2 Adults : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.6 Elderly People
- 11.6.1 Overview
- 11.6.2 Elderly People: Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

12. Middle East & Africa Influenza Vaccines Market Analysis and Forecasts To 2028 - Country Analysis

12.1 Middle East & Africa Influenza Vaccine Market Revenue and Forecasts To 2028
- 12.1.1 Overview
- 12.1.2 Middle East & Africa: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
  - 12.1.2.1 Saudi Arabia: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.1.1 Saudi Arabia: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.1.2 Saudi Arabia: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
    - 12.1.2.1.3 Saudi Arabia: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
    - 12.1.2.1.4 Saudi Arabia Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.1.5 Saudi Arabia Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.1.6 Saudi Arabia: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  - 12.1.2.2 UAE: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.2.1 UAE: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.2.2 UAE: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
    - 12.1.2.2.3 UAE: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
    - 12.1.2.2.4 UAE Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.2.5 UAE Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.2.6 UAE: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  - 12.1.2.3 South Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.3.1 South Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.3.2 South Africa: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
    - 12.1.2.3.3 South Africa: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
    - 12.1.2.3.4 South Africa Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.3.5 South Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.3.6 South Africa: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  - 12.1.2.4 Rest of Middle East & Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.4.1 Rest of Middle East & Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.4.2 Rest of Middle East & Africa: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
    - 12.1.2.4.3 Rest of Middle East & Africa: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
    - 12.1.2.4.4 Rest of Middle East & Africa: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
    - 12.1.2.4.5 Rest of Middle East & Africa: Influenza Vaccine Market, by Route of Administration, 2019-2028 (USD Million)
    - 12.1.2.4.6 Rest of Middle East & Africa: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)

13. Middle East & Africa Influenza Vaccine Market -Industry Landscape

13.1 Overview
13.2 Growth Strategies in the Influenza Vaccine Market, 2021-2028
13.3 Inorganic Growth Strategies
- 13.3.1 Overview
13.4 Organic Growth Strategies
- 13.4.1 Overview

14. Company Profiles

14.1 SEQIRUS
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Sanofi
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 GlaxoSmithKline plc.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Mitsubishi Chemical Group Corporation
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Serum Institute of India Pvt. Ltd
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 MYLAN N.V.
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 AstraZeneca
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms